Abstract
Borrelia miyamotoi is a newly recognized human pathogen in the relapsing fever group of spirochetes. We investigated a case of B. miyamotoi infection of the central nervous system resembling B. burgdorferi-induced Lyme neuroborreliosis and determined that this emergent agent of central nervous system infection can be diagnosed with existing methods.
Keywords:
Borrelia miyamotoi; Germany; Lyme neuroborreliosis; bacteria; immunocompromised persons; neuroborreliosis; ticks; vector-borne infections.
MeSH terms
-
Aged
-
Antibodies, Bacterial / immunology
-
Antineoplastic Combined Chemotherapy Protocols
-
Biomarkers
-
Borrelia Infections / diagnosis*
-
Borrelia Infections / immunology
-
Borrelia Infections / microbiology*
-
Borrelia* / classification
-
Borrelia* / genetics
-
Borrelia* / immunology
-
Central Nervous System Bacterial Infections / diagnosis*
-
Central Nervous System Bacterial Infections / immunology
-
Central Nervous System Bacterial Infections / microbiology*
-
Female
-
Genes, Bacterial
-
Humans
-
Immunocompromised Host*
-
Lymphoma, Non-Hodgkin / complications
-
Lymphoma, Non-Hodgkin / diagnosis
-
Lymphoma, Non-Hodgkin / drug therapy
-
Multilocus Sequence Typing
-
RNA, Ribosomal, 16S / genetics
Substances
-
Antibodies, Bacterial
-
Biomarkers
-
RNA, Ribosomal, 16S